CD8A and mantle cell lymphoma: There was no significant difference in PD-L1 expression among various risk groups, but the density of CD8+ T lymphocytes showed a negative correlation with risk stratification, suggesting that CD8+ T lymphocytes might be a useful prognostic biomarker for risk stratification of MCL patients, consistent with other previous studies (Nygren et al., 2014).